Evidence map›Paper›PMID 39133931›Full record

ArticleBlood2024

Unbalanced MYC break-apart FISH patterns indicate the presence of a MYC rearrangement in HGBCL-DH-BCL2.

Brett Collinge, Susana Ben-Neriah, Laura K Hilton, Waleed Alduaij, Tracy Tucker, Graham W Slack, Pedro Farinha, Jeffrey W Craig, Merrill Boyle, Barbara Meissner and 8 more

Abstract read
In one paragraph

Article in Blood, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Brett CollingeCentre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.ORCID 0000-0002-5860-2798
Susana Ben-NeriahCentre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.ORCID 0000-0002-2867-4037
Laura K HiltonCentre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.ORCID 0000-0002-6413-6586
Waleed AlduaijCentre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.ORCID 0000-0002-2365-5371
Tracy TuckerCancer Genetics and Genomics Laboratory, BC Cancer, Vancouver, BC, Canada.
Graham W SlackCentre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
Pedro FarinhaCentre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.ORCID 0000-0001-9364-9391
Jeffrey W CraigDepartment of Pathology, University of Virginia, Charlottesville, VA.ORCID 0000-0003-1295-3258
Merrill BoyleCentre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.ORCID 0000-0002-7618-0103
Barbara MeissnerCentre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
Diego VillaCentre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.ORCID 0000-0002-4625-3009
Alina S GerrieCentre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.ORCID 0000-0003-4727-1425
Laurie H SehnCentre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.ORCID 0000-0003-1860-9765
Kerry J SavageCentre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.ORCID 0000-0002-5835-9863
Ryan D MorinCentre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.ORCID 0000-0003-2932-7800
Andrew J MungallCanada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.ORCID 0000-0002-0905-2742
Christian SteidlCentre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.ORCID 0000-0001-9842-9750
David W ScottCentre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.ORCID 0000-0002-0435-5947

Funding

Preclinical Models and Therapeutics CoreP01CA229100 · NCI · MAYO CLINIC ARIZONA · PI SCOTT, DAVID WILLIAM · 2018 to 2022
$10.2M
NCI NIH HHS P01 CA229100
6 · The paper itself

Abstract

abstractFluorescence in situ hybridization (FISH) using break-apart probes is recommended for identifying high-grade B-cell lymphoma with MYC and BCL2 rearrangements (HGBCL-DH-BCL2). Unbalanced MYC break-apart patterns, in which the red or green signal is lost, are commonly reported as an equivocal result by clinical laboratories. In a cohort of 297 HGBCL-DH-BCL2, 13% of tumors had unbalanced MYC break-apart patterns with loss of red (LR; 2%) or loss of green (LG; 11%) signal. To determine the significance of these patterns, MYC rearrangements were characterized by sequencing in 130 HGBCL-DH-BCL2, including 3 LR and 14 LG tumors. A MYC rearrangement was identified for 71% of tumors with LR or LG patterns, with the majority involving immunoglobulin loci or other recurrent MYC rearrangement partners. The architecture of these rearrangements consistently preserved the rearranged MYC allele, with the MYC gene predicted to be on the derivative chromosome containing the signal that is still present in nearly all cases. MYC protein expression, MYC messenger RNA expression, and the proportion of tumors expressing the dark-zone signature was not significantly different between balanced and unbalanced groups. These results support a recommendation that unbalanced MYC break-apart FISH patterns be reported as positive for MYC rearrangement in the context of diagnosing HGBCL-DH-BCL2.

Indexed as

Gene RearrangementIn Situ Hybridization, FluorescenceProto-Oncogene Proteins c-bcl-2Proto-Oncogene Proteins c-mycFemaleGenes, mycHumansLymphoma, B-CellMaleBCL2 protein, humanMYC protein, humanProto-Oncogene Proteins c-bcl-2Proto-Oncogene Proteins c-myc

Identifiers

PMID39133931
PMCPMC11487639

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.